Tibet Duo Rui Pharmaceutical Co., Ltd. (SHE:301075)

China flag China · Delayed Price · Currency is CNY
94.31
+3.79 (4.19%)
At close: Mar 10, 2026
373.92%
Market Cap 7.45B
Revenue (ttm) 177.11M
Net Income (ttm) -125.32M
Shares Out 78.96M
EPS (ttm) -1.61
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,715,978
Average Volume 1,245,621
Open 90.50
Previous Close 90.52
Day's Range 87.90 - 98.29
52-Week Range 19.00 - 94.31
Beta 0.26
RSI 87.60
Earnings Date Apr 29, 2026

About SHE:301075

Tibet Duo Rui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations, intermediates, and raw materials in China. It offers fluid therapy, anesthesiology medication, analgesic medication, and first-aid medication products, as well as sodium acetate ringer's injection; and agent products, such as amoxicillin sodium and clavulanate potassium for injection, etc. The company was founded in 2005 and is headquartered in Tibet, China. [Read more]

Sector Healthcare
Founded 2005
Employees 497
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301075
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.